Development of SYK NanoBRET cellular target engagement assays for gain-of-function variants.
Saved in:
| Title: | Development of SYK NanoBRET cellular target engagement assays for gain-of-function variants. |
|---|---|
| Authors: | Capener JL; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Vasta JD; Promega Corporation, Madison, WI, United States., Katis VL; ARUK Oxford Drug Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Michaud A; Promega Corporation, Madison, WI, United States., Beck MT; Promega Corporation, Madison, WI, United States., Daglish SCD; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Cohen-Kedar S; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.; Felsenstein Medical Research Center, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Barda ES; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.; Felsenstein Medical Research Center, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Howell S; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Dotan I; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.; Felsenstein Medical Research Center, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel., Robers MB; Promega Corporation, Madison, WI, United States., Axtman AD; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Bashore FM; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. |
| Source: | Frontiers in chemical biology [Front Chem Biol] 2024; Vol. 3. Date of Electronic Publication: 2024 Jul 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918716583206676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2813-530X (Electronic) Linking ISSN: 2813530X NLM ISO Abbreviation: Front Chem Biol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42004161 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of SYK NanoBRET cellular target engagement assays for gain-of-function variants. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Capener+JL%22">Capener JL</searchLink>; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.<br /><searchLink fieldCode="AU" term="%22Vasta+JD%22">Vasta JD</searchLink>; Promega Corporation, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Katis+VL%22">Katis VL</searchLink>; ARUK Oxford Drug Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Michaud+A%22">Michaud A</searchLink>; Promega Corporation, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Beck+MT%22">Beck MT</searchLink>; Promega Corporation, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Daglish+SCD%22">Daglish SCD</searchLink>; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.<br /><searchLink fieldCode="AU" term="%22Cohen-Kedar+S%22">Cohen-Kedar S</searchLink>; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.; Felsenstein Medical Research Center, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Barda+ES%22">Barda ES</searchLink>; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.; Felsenstein Medical Research Center, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Howell+S%22">Howell S</searchLink>; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.<br /><searchLink fieldCode="AU" term="%22Dotan+I%22">Dotan I</searchLink>; Division of Gastroenterology, Rabin Medical Center, Petah-Tikva, Israel.; Felsenstein Medical Research Center, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Robers+MB%22">Robers MB</searchLink>; Promega Corporation, Madison, WI, United States.<br /><searchLink fieldCode="AU" term="%22Axtman+AD%22">Axtman AD</searchLink>; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.<br /><searchLink fieldCode="AU" term="%22Bashore+FM%22">Bashore FM</searchLink>; Structural Genomics Consortium, Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918716583206676%22">Frontiers in chemical biology</searchLink> [Front Chem Biol] 2024; Vol. 3. <i>Date of Electronic Publication: </i>2024 Jul 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918716583206676 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2813-530X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222813530X%22">2813530X </searchLink><i>NLM ISO Abbreviation: </i>Front Chem Biol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42004161 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fchbi.2024.1447622 Languages: – Code: eng Text: English Titles: – TitleFull: Development of SYK NanoBRET cellular target engagement assays for gain-of-function variants. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Capener JL – PersonEntity: Name: NameFull: Vasta JD – PersonEntity: Name: NameFull: Katis VL – PersonEntity: Name: NameFull: Michaud A – PersonEntity: Name: NameFull: Beck MT – PersonEntity: Name: NameFull: Daglish SCD – PersonEntity: Name: NameFull: Cohen-Kedar S – PersonEntity: Name: NameFull: Barda ES – PersonEntity: Name: NameFull: Howell S – PersonEntity: Name: NameFull: Dotan I – PersonEntity: Name: NameFull: Robers MB – PersonEntity: Name: NameFull: Axtman AD – PersonEntity: Name: NameFull: Bashore FM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2024 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2813-530X Numbering: – Type: volume Value: 3 Titles: – TitleFull: Frontiers in chemical biology Type: main |
| ResultId | 1 |